Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Stutterheim · SciRah

Researcher profile · Semantic Scholar

J. Stutterheim

Share profile

J. Stutterheim — researcher profile on SciRah

h-index: 18
Works: 42
Citations: 814

Most-cited papers

PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
J. Stutterheim, A. Gerritsen, Lily Zappeij-Kannegieter, I. Kleijn +9 more
2008Journal of Clinical Oncology108 citations
Semantic Scholar
Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.
J. Stutterheim, A. Gerritsen, Lily Zappeij-Kannegieter, B. Yalçın +7 more
2009Clinical Chemistry90 citations Open access
Semantic Scholar
The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma.
J. Stutterheim, Lily Zappeij-Kannegieter, R. Versteeg, H. Caron +2 more
2011European Journal of Cancer64 citations Open access
Semantic Scholar
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
J. Stutterheim, I. M. van der Sluis, P. de Lorenzo, J. Alten +23 more
2021Journal of Clinical Oncology57 citations Open access
Semantic Scholar
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
R. Tirtakusuma, K. Szoltysek, P. Milne, Vasily V. Grinev +53 more
2022Blood56 citations Open access
Semantic Scholar
HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity.
J. V. van Gils, J. Stutterheim, Trynette J. van Duijn, J. Zwaginga +3 more
2009Molecular Immunology41 citations
Semantic Scholar
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community
Branko Cuglievan, H. Kantarjian, J. Rubnitz, Todd M. Cooper +43 more
2024Leukemia33 citations Open access
Semantic Scholar
Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma
J. Stutterheim, F. A. Ichou, E. den Ouden, R. Versteeg +3 more
2011Clinical Cancer Research33 citations
Semantic Scholar
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
R. van Paemel, Charlotte Vandeputte, L. Raman, Jolien Van Thorre +22 more
2021European Journal of Cancer28 citations Open access
Semantic Scholar
Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors
L. V. van Zogchel, N. Lak, O. Verhagen, Ahmed Tissoudali +11 more
2021JCO Precision Oncology28 citations Open access
Semantic Scholar
Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma
E. V. van Wezel, J. Stutterheim, Florentien E. M. Vree, Lily Zappeij-Kannegieter +11 more
2015Pediatric Blood & Cancer28 citations Open access
Semantic Scholar
Stability of PCR targets for monitoring minimal residual disease in neuroblastoma.
J. Stutterheim, Lily Zappeij-Kannegieter, I. Øra, P. van Sluis +6 more
2012Journal of Molecular Diagnostics28 citations Open access
Semantic Scholar
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study
O. Ruhen, N. Lak, J. Stutterheim, S. Danielli +32 more
2022JCO Precision Oncology26 citations Open access
Semantic Scholar
Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR
L. V. van Zogchel, Lily Zappeij-Kannegieter, Ahmad Javadi, Marjolein Lugtigheid +7 more
2021Cancers26 citations Open access
Semantic Scholar
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic and Myeloid Leukemia
Fabienne R. S. Adriaanse, P. Schneider, S. Arentsen-Peters, Ana M. Neves da Fonseca +4 more
2024International Journal of Molecular Sciences25 citations Open access
Semantic Scholar
Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma
L. V. van Zogchel, E. V. van Wezel, Jalenka van Wijk, J. Stutterheim +7 more
2020JCO Precision Oncology25 citations Open access
Semantic Scholar
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma
N. Lak, L. V. van Zogchel, Lily Zappeij-Kannegieter, Ahmad Javadi +15 more
2023JCO Precision Oncology24 citations Open access
Semantic Scholar
Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease
N. Lak, Timon L Voormanns, Lily Zappeij-Kannegieter, L. V. van Zogchel +6 more
2021Clinical Cancer Research22 citations Open access
Semantic Scholar
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.
J. Stutterheim, P. de Lorenzo, I. M. van der Sluin, J. Alten +23 more
2021European Journal of Cancer17 citations Open access
Semantic Scholar
Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
E. V. van Wezel, B. Decarolis, J. Stutterheim, Lily Zappeij-Kannegieter +9 more
2016European Journal of Cancer17 citations Open access
Semantic Scholar
Epigenetic regulator genes direct lineage switching in MLL-AF4 leukaemia
R. Tirtakusuma, K. Szoltysek, P. Milne, V. Grinev +48 more
2021bioRxiv13 citations Open access
Semantic Scholar
Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential
N. Lak, Anne Seijger, L. V. van Zogchel, Nina U. Gelineau +8 more
2023Cancers10 citations Open access
Semantic Scholar
Sensitive liquid biopsy monitoring correlates with outcome in the prospective international GPOH-DCOG high-risk neuroblastoma RT-qPCR validation study
L. V. van Zogchel, B. Decarolis, E. V. van Wezel, Lily Zappeij-Kannegieter +10 more
2024Journal of experimental & clinical cancer research : CR5 citations Open access
Semantic Scholar
Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors
L. V. van Zogchel, N. Lak, Nina U. Gelineau, I. Sergeeva +16 more
2023Frontiers in Oncology5 citations Open access
Semantic Scholar
Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?
J. Stutterheim, Rachella van der Waarden, H. D. de Groot-Kruseman, E. Sonneveld +5 more
2024Leukemia3 citations Open access
Semantic Scholar
Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation Study
Nina U. Gelineau, L. V. van Zogchel, B. Decarolis, E. V. van Wezel +11 more
2025JCO Precision Oncology1 citations Open access
Semantic Scholar
Abstract A53: Hypermethylated RASSF1A as circulating tumor marker in pediatric and adolescent solid tumors
L. V. van Zogchel, J. Lobo, N. Lak, E. V. van Wezel +6 more
2020Poster Presentations - Proffered Abstracts1 citations
Semantic Scholar
Clinical Implications of Minimal Residual Disease Detection in Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
J. Stutterheim, I. M. van der Sluis, P. de Lorenzo, J. Alten +22 more
2020Blood1 citations
Semantic Scholar
Minimal residual disease monitoring in neuroblastoma
E. V. van Wezel, J. Stutterheim, Florentien Vree, Lily Zappeij-Kannegieter +14 more
20161 citations
Semantic Scholar
Pediatric Neuroblastoma: Molecular Detection of Minimal Residual Disease
J. Stutterheim, G. Tytgat, C. Ellen van der Schoot
20121 citations
Semantic Scholar
Longitudinal Neuropsychological Outcomes After Pediatric non-CNS Cancer Diagnosis and the Role of Neurological Complications
M. Huisman, Margreet Tissing, L. Haveman, J. Stutterheim +4 more
2026EJC Paediatric Oncology0 citations Open access
Semantic Scholar
P366: ARE MINIMAL RESIDUAL DISEASE MEASUREMENTS AFTER CONSOLIDATION THERAPY USEFUL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA?
J. Stutterheim, Rachella van der Waarden, H. D. de Groot-Kruseman, E. Sonneveld +5 more
2023HemaSphere0 citations Open access
Semantic Scholar
Inhibition of the Menin-MLL1 Interaction in MLL-Rearranged Primary Mixed-Phenotype Acute Leukemia Samples Promotes Leukemic Differentiation
K. Szoltysek, Rachel Cameron, A. Krippner-Heidenreich, Milad Rasouli +6 more
2022Blood0 citations
Semantic Scholar
Minimal Residual Disease and Outcome Characteristics in Infant KMT2A-Germline Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
J. Stutterheim, P. de Lorenzo, I. M. van der Sluis, J. Alten +23 more
2021Blood0 citations Open access
Semantic Scholar
Abstract B56: Neuroblastoma patient-derived tumor-specific mRNA and DNA in platelets and extracellular vesicles
N. Lak, L. V. van Zogchel, Lily Zappeij-Kannegieter, J. Stutterheim +2 more
20200 citations
Semantic Scholar
minimal Bone Marrow Disease Is Frequently Detected In Localized Neuroblastoma Patients : pd-062
E. V. van Wezel, B. Decarolis, J. Stutterheim, Lily Zappeij-Kannegieter +9 more
20150 citations
Semantic Scholar
Minimal residual disease detection and monitoring in children with neuroblastoma
J. Stutterheim
20110 citations
Semantic Scholar
Minimal residual disease detection and monitoring in children with neuroblastoma
J. Stutterheim, A. Gerritsen, I. Kleijn, R. Dee +8 more
20110 citations
Semantic Scholar
Abstract LB-312: Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma
J. Stutterheim, F. A. Ichou, E. den Ouden, R. Versteeg +3 more
20110 citations
Semantic Scholar
Abstract 844: Tumor cell detection in autologous stem cell harvests in patients with high risk neuroblastoma
J. Stutterheim, Florentien E. M. Vree, Lily Zappeij-Kannegieter, H. Caron +2 more
20100 citations
Semantic Scholar
Abstract 843: Fast molecular response of marrow disease is highly prognostic in stage 4 neuroblastoma > 1 year
J. Stutterheim, Lily Zappeij-Kannegieter, R. Versteeg, C. Ellen van der Schoot +2 more
20100 citations
Semantic Scholar
Comparison of quantiﬁcation of MRD levels in BM applying RASSF1a
J. Stutterheim, F. A. Ichou, E. den Ouden, R. Versteeg +3 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Tytgat×25
Invite
G. Tytgat — researcher profile on SciRah
C. Ellen van der Schoot×21
Invite
C. Ellen van der Schoot — researcher profile on SciRah
Lily Zappeij-Kannegieter×19
Invite
Lily Zappeij-Kannegieter — researcher profile on SciRah
L. V. van Zogchel×12
Invite
L. V. van Zogchel — researcher profile on SciRah

M. V. van Noesel×10

Invite

M. V. van Noesel — researcher profile on SciRah

Invite

N. Lak — researcher profile on SciRah

Invite

R. Versteeg — researcher profile on SciRah

Invite

M. Fiocco — researcher profile on SciRah

Invite

H. Caron — researcher profile on SciRah

E. V. van Wezel×8

Invite

E. V. van Wezel — researcher profile on SciRah

Invite

F. Berthold — researcher profile on SciRah

Invite

H. Caron — researcher profile on SciRah